| Multimodal techniques for diagnosis and prognosis of Alzheimer's disease RJ Perrin, AM Fagan, DM Holtzman Nature 461 (7266), 916-922, 2009 | 886 | 2009 |
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease O Preische, SA Schultz, A Apel, J Kuhle, SA Kaeser, C Barro, S Gräber, ... Nature medicine 25 (2), 277-283, 2019 | 859 | 2019 |
| Interaction of human α-synuclein and Parkinson's disease variants with phospholipids: structural analysis using site-directed mutagenesis RJ Perrin, WS Woods, DF Clayton, JM George Journal of Biological Chemistry 275 (44), 34393-34398, 2000 | 589 | 2000 |
| A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer’s disease NR Barthélemy, Y Li, N Joseph-Mathurin, BA Gordon, J Hassenstab, ... Nature medicine 26 (3), 398-407, 2020 | 534 | 2020 |
| YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease R Craig-Schapiro, RJ Perrin, CM Roe, C Xiong, D Carter, NJ Cairns, ... Biological psychiatry 68 (10), 903-912, 2010 | 525 | 2010 |
| Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins RJ Perrin, WS Woods, DF Clayton, JM George Journal of Biological Chemistry 276 (45), 41958-41962, 2001 | 352 | 2001 |
| A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease S Salloway, M Farlow, E McDade, DB Clifford, G Wang, JJ Llibre-Guerra, ... Nature medicine 27 (7), 1187-1196, 2021 | 318 | 2021 |
| An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations U Dube, JL Del-Aguila, Z Li, JP Budde, S Jiang, S Hsu, L Ibanez, ... Nature neuroscience 22 (11), 1903-1912, 2019 | 301 | 2019 |
| Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy S Da Mesquita, Z Papadopoulos, T Dykstra, L Brase, FG Farias, M Wall, ... Nature 593 (7858), 255-260, 2021 | 284 | 2021 |
| Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease WT Hu, DM Holtzman, AM Fagan, LM Shaw, R Perrin, SE Arnold, ... Neurology 79 (9), 897-905, 2012 | 275 | 2012 |
| Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis R Craig-Schapiro, M Kuhn, C Xiong, EH Pickering, J Liu, TP Misko, ... PloS one 6 (4), e18850, 2011 | 267 | 2011 |
| Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns FJ Wippold, M Lubner, RJ Perrin, M Lämmle, A Perry American Journal of Neuroradiology 28 (9), 1633-1638, 2007 | 250 | 2007 |
| Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease RJ Perrin, R Craig-Schapiro, JP Malone, AR Shah, P Gilmore, AE Davis, ... PloS one 6 (1), e16032, 2011 | 234 | 2011 |
| Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders C Yang, FHG Farias, L Ibanez, A Suhy, B Sadler, MV Fernandez, F Wang, ... Nature neuroscience 24 (9), 1302-1312, 2021 | 189 | 2021 |
| Parenchymal border macrophages regulate the flow dynamics of the cerebrospinal fluid A Drieu, S Du, SE Storck, J Rustenhoven, Z Papadopoulos, T Dykstra, ... Nature 611 (7936), 585-593, 2022 | 177 | 2022 |
| A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain JL Del-Aguila, Z Li, U Dube, KA Mihindukulasuriya, JP Budde, ... Alzheimer's research & therapy 11, 1-16, 2019 | 177 | 2019 |
| Augmentation of lung liquid clearance via adenovirus-mediated transfer of a Na, K-ATPase beta1 subunit gene. P Factor, F Saldias, K Ridge, V Dumasius, J Zabner, HA Jaffe, G Blanco, ... The Journal of clinical investigation 102 (7), 1421-1430, 1998 | 169 | 1998 |
| Cocaine abusers have an overexpression of α-synuclein in dopamine neurons DC Mash, Q Ouyang, J Pablo, M Basile, S Izenwasser, A Lieberman, ... Journal of Neuroscience 23 (7), 2564-2571, 2003 | 157 | 2003 |
| Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer’s disease AM Fagan, RJ Perrin Biomarkers in medicine 6 (4), 455-476, 2012 | 156 | 2012 |
| Structural determinants of PLD2 inhibition by α-synuclein JE Payton, RJ Perrin, WS Woods, JM George Journal of molecular biology 337 (4), 1001-1009, 2004 | 154 | 2004 |
Randall BatemanWashington University in St. LouisCorreu electrònic verificat a wustl.edu
